• Pharmaceutical
• Biologics
• Combination Product
• Medical Devices
• Toxicology

News & Events

WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training

March 2, 2010 

March 2, 2010 – Shanghai, China – WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V. (JANSSEN), to collaborate in the area of preclinical services.

Continue Reading... 

Press Releases  

  

02/23/2010
WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 

02/22/2010
WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility

01/20/2010
WuXi PharmaTech (NYSE: WX) Welcomes Mr. Wu Bangguo in Its Preclinical Testing Facility 

12/22/2009
WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing 

12/22/2009
WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year 

12/07/2009
WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening

11/30/2009
WuXi PharmaTech Awarded in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year

10/30/2009
WuXi AppTec Receives 2009 Schering-Plough Excellence Award

10/22/2009

WuXi PharmaTech Appoints Dr. Hui Cai as Vice President of Business Development 

08/14/2009
WuXi PharmaTech Selected as One of the Top Ten Employers for New College Graduates in Pharmaceutical Industry in 2009 

07/23/2009
WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology 

06/30/2009
WuXi PharmaTech Receives Award from BASF

06/26/2009
WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise

06/26/2009
WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations

06/22/2009
WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services

05/05/2009
WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance

05/05/2009

WuXi AppTec Receives 2009 Lilly Global Supplier Award 

03/31/2009


WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection 

03/24/2009

WuXi AppTec Welcomes Three Senior Professionals

03/17/2009

Professor K. C. Nicolaou Speaks at WuXi AppTec

02/17/2009

WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO

02/10/2009
WuXi AppTec Successfully Holds Its 2009 Supplier Conference in Shanghai

02/08/2009
WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year

02/05/2009
WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board

01/12/2009
St. Paul and Atlanta Laboratories of WuXi PharmaTech (NYSE:WX) Receive ISO/IEC 17025:2005 Accreditation  

WuXi AppTec In the News

WuXi Pharmatech Featured in The Fast Company 50 2009
Source: Fast Company, 2/11/2009

Right Mix
Source: ChinaDaily 3/24/2008

New prescription
Source: ChinaDaily 3/24/2008

No Slowdown for China's WuXi
Source: The Motley Fool 3/14/2008

Drug Makers Stick by China
Source: Boston Globe 3/14/2008

China's WuXi gets U.S. okay to buy AppTec
Source: Reuters 1/23/2008

Bringing it back to the States
Source: Contract Pharma 1/22/2008

WuXi's AppTec Deal Is Move For Bigger Market Share
Source: The Wall Street Journal 1/5/2008

Wuxi Makes $160 Million Offer for AppTec of U.S.
Source: Bloomberg 1/4/2008